Richmond Pharmacology is pleased to attend the ESC Heart Failure Congress in Barcelona, Spain, on 09 -12 May 2026.

This leading event brings together cardiology experts, researchers, and industry innovators to advance heart failure care through cutting-edge science, clinical insights, and collaborative solutions.

Representing Richmond Pharmacology

  • Jörg Taubel, Chief Executive Officer

We look forward to connecting with attendees to discuss Richmond’s expertise in:

  • Innovations in heart failure drug development
  • Clinical trial design for complex cardiac conditions
  • Regulatory pathways for novel therapies
  • Patient-centric approaches and recruitment strategies
  • Collaboration between academia, industry, and regulators

Connect With Us

If you are attending ESC Heart Failure 2026 and would like to explore partnership or development opportunities email us at:

📧 fasteranswers@richmondpharmacology.com

Latest news

Leadership Spotlight- Head of Acute Clinical Management

February 20, 2026
In this edition, we spotlight Carolina Pacheco de Amorim, who leads Acute Clinical Management (ACM)
Read more

Events

Clinical Trials Innovation Programme

10 - 11 February 2026
Richmond Pharmacology is pleased to attend the Clinical Trials Innovation Programme Conference in Nice, France, 10–11 February 2026.
View event